# Cellicure, Inc. — Form D

Cellicure, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-09. The offering totals $3.9M, of which $3.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-05-09
- Form: D
- Accession: 0001926980-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.9M
- Amount sold: $3.9M
- Investors: 7
- Date of first sale: 2021-07-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-444909

## Issuer

- Name: Cellicure, Inc.
- CIK: 0001926980
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 2200 RESEARCH BLVD, SUITE 550, ROCKVILLE, MD, 20850
- Phone: 3016615015

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Qisheng Li | Director | Rockville, MD |
| Minggang Zhang | Director | Rockville, MD |
| Wang X Belle | Executive Officer | Rockville, MD |
| Qisheng Li | Executive Officer | Rockville, MD |
| Minggang Zhang | Executive Officer | Rockville, MD |

## More

- [CIK 1926980 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1926980&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001926980-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.